Table 1. Baseline characteristics of study patients.
| Characteristics | Values |
| Age (a) | |
| Mean (range) | 64 (42-88) |
| Sex | |
| M | 31 (53) |
| F | 28 (47) |
| Race | |
| Caucasian | 23 (39) |
| Black | 24 (41) |
| Asian | 12 (20) |
| Diagnosis | |
| OHT | 43 (73) |
| POAG | 6 (10) |
| NTG | 4 (7) |
| PAC-OHT | 5 (8) |
| PACG | 1 (2) |
| IOP-lowering Rx | |
| Latanoprost | 39 (66) |
| Travoprost | 11 (19) |
| Travoprost/Timolol combination drop | 3 (5) |
| Latanoprost+Dorzolamide/Timolol combination drop | 2 (3) |
| Dorzolamide+Travoprost/Timolol combination drop | 2 (3) |
| Brinzolamide+Bimatoprost/Timolol combination drop | 1 (2) |
| Latanoprost/Timolol combination drop | 1 (2) |
| Mean Pre-switch IOP (mm Hg) | |
| Right eye | 23.2±4.4 |
| Left eye | 23.3±3.7 |
n (%)